[老年人的前性痴呆:实用工具]
Niek Verwey1,2, Yolande Pijnenburg2,3, Floor Duits2,3
1Geheugenpolikliniek, Medisch Centrum Leeuwarden, Leeuwarden.
Tijdschrift voor gerontologie en geriatrie
|December 17, 2025
概括
前性痴呆症 (FTD) 是老年人痴呆的一个罕见原因. 这篇文章重点介绍了两个病例,以提高认识和及时诊断,以便更好地照顾患者.
科学领域:
- 神经学 神经学
- 老年病的医生 老年病的医生
- 神经科学是一个神经科学.
背景情况:
- 前性痴呆症 (FTD) 通常影响年轻人.
- 诊断FTD是具有挑战性的,因为不同的症状往往被误认为是其他疾病.
- FTD可以发生在老年人身上,尽管它很罕见.
研究的目的:
- 在老年人中呈现两例FTD病例.
- 提高老年人群对FTD的认识.
- 强调及时准确诊断的重要性.
主要方法:
- 案例报告的呈现方式.
- 对临床症状和诊断挑战的审查.
- 在老年认知障碍的背景下讨论FTD.
主要成果:
- 在老年人中详细介绍了两例FTD病例.
- 描述了在老年患者中诊断FTD的复杂性.
- 突出了将症状错误归因于更常见的原因的可能性.
结论:
- 在有认知和行为变化的老年人中,FTD是一个重要的考虑因素.
- 早期和精确的FTD诊断对于有效的管理至关重要.
- 提高认识可以为FTD影响的患者和家人提供更好的支持.
相关概念视频
Dementia
486
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
486
Alzheimer's Disease: Treatment
752
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
752
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K


